CoQ10

Coenzyme Q10

Vitaminas e minerais

Última revisão: 7 de abril de 2026. Abordagem de fontes: contexto padrão de interpretação laboratorial, material médico de referência e orientações clínicas ou de saúde pública quando relevantes.

O que é Coenzyme Q10?

Coenzyme Q10 (CoQ10), also known as ubiquinone (oxidized form) or ubiquinol (reduced form), is a lipid-soluble, vitamin-like compound found in virtually all cells of the body. Its name "ubiquinone" reflects its ubiquitous presence. CoQ10 plays two essential roles: it serves as an electron carrier in the mitochondrial electron transport chain (complexes I through III), where it is indispensable for aerobic ATP production, and it functions as a potent lipid-soluble antioxidant that protects cell membranes and lipoproteins from oxidative damage.

The body synthesizes CoQ10 endogenously through the mevalonate pathway—the same pathway used to produce cholesterol—which is why statin medications (HMG-CoA reductase inhibitors) can reduce CoQ10 levels. Dietary sources include organ meats, beef, sardines, mackerel, peanuts, and soybeans, though dietary contribution is modest compared to endogenous synthesis in healthy individuals. CoQ10 levels in blood and tissues decline with age, and certain diseases—particularly heart failure, neurodegenerative conditions, and mitochondrial myopathies—are associated with reduced CoQ10 status. Plasma CoQ10 levels reflect both endogenous synthesis and supplementation.

Por que isso importa

CoQ10 is essential for mitochondrial energy production—organs with the highest energy demands (heart, brain, kidneys, liver, skeletal muscle) have the highest CoQ10 concentrations and are most vulnerable to depletion. The heart, beating over 100,000 times daily, is particularly dependent on CoQ10-mediated ATP generation. CoQ10 depletion has been linked to heart failure progression, statin-induced myopathy, and age-related mitochondrial dysfunction. As an antioxidant, CoQ10 protects LDL cholesterol from oxidation (a key step in atherosclerosis) and regenerates other antioxidants including vitamin E. Supplementation has shown benefit in heart failure, statin myalgia, and certain mitochondrial disorders.

Faixas de referência normais

GrupoFaixaUnidade
Adults (plasma)0.5–1.7µg/mL
Therapeutic target (heart failure)>2.0µg/mL

As faixas de referência podem variar entre laboratórios. Sempre compare seus resultados com as faixas fornecidas pelo seu local de exame.

O que significam níveis altos de CoQ10

Causas comuns

  • CoQ10 supplementation
  • Hyperlipidemia (CoQ10 is carried by lipoproteins)

Possíveis sintomas

  • Generally well-tolerated even at high supplemental doses
  • Mild gastrointestinal symptoms (nausea, diarrhea) at doses >600 mg/day
  • Insomnia when taken late in the day
  • Possible reduction of warfarin efficacy (shares structural similarity with vitamin K)

O que fazer: CoQ10 has an excellent safety profile and no established toxic upper limit. Doses up to 1,200 mg daily have been used in clinical trials without serious adverse effects. If gastrointestinal symptoms occur, divide the dose or take with food. Patients on warfarin should have INR monitored when starting CoQ10, as it may reduce anticoagulant effect. Adjust lipid levels when interpreting plasma CoQ10 (cholesterol-adjusted ratio provides more accurate assessment).

O que significam níveis baixos de CoQ10

Causas comuns

  • Statin therapy (inhibits mevalonate pathway, reducing CoQ10 synthesis)
  • Aging (endogenous production declines after age 40)
  • Heart failure and cardiomyopathy
  • Primary CoQ10 deficiency (rare genetic disorders)
  • Mitochondrial diseases
  • Beta-blockers and certain other cardiovascular medications
  • Diabetes mellitus

Possíveis sintomas

  • Fatigue and exercise intolerance
  • Muscle weakness, pain, or cramps (particularly with statins)
  • Heart failure symptoms (dyspnea, edema, reduced exercise capacity)
  • Cognitive impairment
  • In primary deficiency: encephalopathy, seizures, nephrotic syndrome

O que fazer: For statin-related myalgia, 100–200 mg daily of CoQ10 (ubiquinol form for better absorption) may reduce symptoms, though evidence is mixed. Heart failure patients have shown benefit with 100–300 mg daily in multiple trials (Q-SYMBIO showed reduced mortality). Primary CoQ10 deficiency requires high-dose supplementation (5–50 mg/kg/day). Take CoQ10 with a fat-containing meal for optimal absorption. Ubiquinol is better absorbed than ubiquinone, particularly in older individuals.

Quando o exame de CoQ10 é recomendado?

  • In patients with unexplained myopathy, especially those on statins
  • When evaluating mitochondrial disorders
  • In heart failure management
  • When primary CoQ10 deficiency is suspected
  • In patients with unexplained exercise intolerance
  • When monitoring therapeutic supplementation levels

Perguntas frequentes

This remains one of the most debated questions in cardiovascular medicine. Statins inhibit HMG-CoA reductase—the same enzyme needed for CoQ10 synthesis—and can reduce blood CoQ10 levels by 16–54%. However, whether this reduction is clinically meaningful is unclear. Some patients develop statin-related muscle symptoms that improve with CoQ10 supplementation, while randomized trials have shown mixed results. The American College of Cardiology does not universally recommend CoQ10 with statins but acknowledges it may be tried in patients with statin-associated muscle symptoms before switching medications.
Ubiquinone is the oxidized form of CoQ10, and ubiquinol is the reduced (active) form. In the body, CoQ10 constantly cycles between these two forms as it participates in electron transport and antioxidant functions. Ubiquinol is generally better absorbed orally, particularly in older adults and those with impaired gut absorption, because it does not require the reduction step that ubiquinone does after absorption. However, both forms are ultimately converted as needed in the body, and both are effective when properly dosed.
The Q-SYMBIO trial (2014) showed that CoQ10 supplementation at 300 mg daily for 2 years significantly reduced major adverse cardiovascular events and all-cause mortality in patients with moderate-to-severe heart failure, when added to standard therapy. Earlier and smaller trials also showed improvements in ejection fraction, functional capacity, and symptoms. The European Society of Cardiology recognizes CoQ10 as a potential adjunctive therapy. However, CoQ10 should never replace standard heart failure medications—it is an addition to guideline-directed medical therapy, not a substitute.

Biomarcadores relacionados

Leitura relacionada

Condições

Referências e abordagem de revisão

As páginas do glossário de biomarcadores são explicações educativas e devem ser interpretadas junto com as faixas de referência e observações fornecidas pelo seu laboratório e pelo seu médico. Para conhecer nossos padrões editoriais e processo de revisão, veja nossa Política editorial e a nossa revisão de conteúdo.

Quer analisar seus níveis de CoQ10?

Envie seus resultados de exames para receber uma análise instantânea com IA de todos os seus biomarcadores.

Enviar resultados de exames →

Aviso médico: Estas informações são apenas educativas e não substituem orientação, diagnóstico ou tratamento médico profissional. As faixas de referência podem variar entre laboratórios. Sempre converse com seu profissional de saúde sobre a interpretação dos seus resultados específicos.

Aviso: O SymptomGPT não é uma ferramenta de diagnóstico médico e não oferece aconselhamento médico. Sempre consulte um profissional de saúde qualificado. Se você estiver enfrentando uma emergência médica, ligue para o número de emergência da sua região imediatamente.